BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21323961)

  • 1. Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma.
    Soares AB; Demasi AP; Altemani A; de Araújo VC
    Histopathology; 2011 Feb; 58(3):377-82. PubMed ID: 21323961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation.
    Demasi AP; Furuse C; Soares AB; Altemani A; Araújo VC
    Hum Pathol; 2009 Mar; 40(3):390-7. PubMed ID: 18992915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.
    de Souza AA; Altemani A; Passador-Santos F; Turssi CP; de Araujo NS; de Araújo VC; Soares AB
    Virchows Arch; 2015 Sep; 467(3):295-301. PubMed ID: 26155914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
    Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
    J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: an attempt to predict recurrence of pleomorphic adenoma.
    Soares AB; Altemani A; de Araújo VC
    J Oral Pathol Med; 2011 Apr; 40(4):352-8. PubMed ID: 20969626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy.
    Félix A; Rosa JC; Fonseca I; Cidadão A; Soares J
    Histopathology; 2004 Aug; 45(2):187-92. PubMed ID: 15279638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The increased PDGF-A, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma.
    Soares AB; Demasi AP; Tincani AJ; Martins AS; Altemani A; de Araújo VC
    J Clin Pathol; 2012 Mar; 65(3):272-7. PubMed ID: 22174424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of betacatenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: an immunohistochemical study.
    do Prado RF; Consolaro A; Taveira LA
    Med Oral Patol Oral Cir Bucal; 2006 May; 11(3):E247-51. PubMed ID: 16648762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
    Meer S; Altini M
    Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of the VLA family of integrins in normal salivary gland and in pleomorphic adenoma.
    Sunardhi-Widyaputra S; Van Damme B
    Pathol Res Pract; 1994 Jun; 190(6):600-8. PubMed ID: 7984519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
    Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
    Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomorphological characteristics of pleomorphic adenoma of salivary glands.
    Angelov A; Dikranian K; Trosheva M
    Bull Group Int Rech Sci Stomatol Odontol; 1996; 39(3-4):67-75. PubMed ID: 9203744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin expression in salivary gland tumours.
    Darling MR; Gauthier M; Jackson-Boeters L; Daley TD; Chambers AF; Tuck AB
    Oral Oncol; 2006 Apr; 42(4):363-9. PubMed ID: 16321564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.
    Soares AB; Ponchio L; Juliano PB; de Araújo VC; Altemani A
    J Clin Pathol; 2007 Sep; 60(9):995-1000. PubMed ID: 17079351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macroscopic and microscopic evaluation of pleomorphic adenoma.
    el-Tanany HM; Ayoub MS
    Egypt Dent J; 1993 Jul; 39(3):501-4. PubMed ID: 9669882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrence tendency and malignant transformation of pleomorphic adenomas].
    Chilla R; Schneider K; Droese M
    HNO; 1986 Nov; 34(11):467-9. PubMed ID: 3027008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunological and immunohistochemical study of carcinoembryonic antigen in pleomorphic adenoma and mucoepidermoid carcinoma of the salivary glands.
    Angelov A; Klissarova A; Dikranian K
    Gen Diagn Pathol; 1996 Mar; 141(3-4):229-34. PubMed ID: 8705787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LEF-1: Diagnostic utility in distinguishing basaloid neoplasms of the salivary gland.
    Schmitt AC; Griffith CC; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2017 Dec; 45(12):1078-1083. PubMed ID: 28972308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary epithelial-myoepithelial carcinoma: report of a case misinterpreted as pleomorphic adenoma on fine needle aspiration (FNA).
    Stewart CJ; Hamilton S; Brown IL; MacKenzie K
    Cytopathology; 1997 Jun; 8(3):203-9. PubMed ID: 9202896
    [No Abstract]   [Full Text] [Related]  

  • 20. CD24 and CD44 in salivary gland pleomorphic adenoma and in human salivary gland morphogenesis: differential markers of glandular structure or stem cell indicators?
    Ianez RC; Coutinho-Camillo CM; Buim ME; Pinto CA; Soares FA; Lourenço SV
    Histopathology; 2013 Jun; 62(7):1075-82. PubMed ID: 23600676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.